UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

Vedolizumab as a successful treatment of CTLA-4-associated autoimmune enterocolitis

Navarini, AA; Hruz, P; Berger, CT; Hou, TZ; Schwab, C; Gabrysch, A; Higgins, R; ... Recher, M; + view all (2016) Vedolizumab as a successful treatment of CTLA-4-associated autoimmune enterocolitis. Journal of Allergy and Clinical Immunology 10.1016/j.jaci.2016.08.042. (In press). Green open access

[thumbnail of Navarini_Vedolizumab as a successful treatment.pdf]
Preview
Text
Navarini_Vedolizumab as a successful treatment.pdf - Accepted Version

Download (4MB) | Preview
Type: Article
Title: Vedolizumab as a successful treatment of CTLA-4-associated autoimmune enterocolitis
Location: United States
Open access status: An open access version is available from UCL Discovery
DOI: 10.1016/j.jaci.2016.08.042
Publisher version: http://dx.doi.org/10.1016/j.jaci.2016.08.042
Language: English
Additional information: Copyright © 2016 American Academy of Allergy, Asthma & Immunology. This manuscript version is made available under the CC-BY-NC-ND 4.0 license (http://creativecommons.org/licenses/by-nc-nd/4.0)
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Infection and Immunity
URI: https://discovery.ucl.ac.uk/id/eprint/1534845
Downloads since deposit
175Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item